530125 — Samrat Pharmachem Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹1.09bn
- IN₹1.08bn
- IN₹2.82bn
- 32
- 37
- 38
- 24
2020 March 31st | 2021 March 31st | C2022 March 31st | R2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | PRESS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 11.7 | 25.4 | 147 | 119 | 97.4 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 278 | 330 | 436 | 517 | 693 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 497 | 473 | 713 | 991 | 1,026 |
Net Property, Plant And Equipment | 82.6 | 93.9 | 99.8 | 107 | 107 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 583 | 574 | 846 | 1,166 | 1,217 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 339 | 273 | 373 | 532 | 564 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 340 | 278 | 378 | 534 | 567 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 243 | 296 | 468 | 631 | 650 |
Total Liabilities & Shareholders' Equity | 583 | 574 | 846 | 1,166 | 1,217 |
Total Common Shares Outstanding |